Oscar Health Inc (OSCR) Stock Analysis
Verdict: HOLD
Operational scale is finally driving positive cash flow, but massive insider selling and technical overextension warrant caution at $31.
Investment score: 62/100
Analysis as of
Is Oscar Health Inc stock worth reviewing? The TradeMates thesis
OSCR's fundamental turnaround is real, but the risk/reward is balanced here. The model favors holding rather than new entry due to high beta and insider selling.
7-factor investment score
- Valuation: 70/100 (weight 20%)
- Financial Health: 55/100 (weight 15%)
- Technical Momentum: 75/100 (weight 15%)
- Earnings Quality: 50/100 (weight 15%)
- Insider Sentiment: 20/100 (weight 10%)
- Analyst Consensus: 60/100 (weight 10%)
- Risk-Adjusted Return: 65/100 (weight 15%)
Oscar Health Inc opportunities and risks
What speaks for OSCR
- Scalable Operating Leverage
What speaks against OSCR
- Regulatory and Political Risk
Peers and competitors
- PRU
- PFG
- UNM
- GL
- PRI
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| OSCR | n/a | 0.6x | 194.4x | 17.4% | -0.3% | 34.5% |
| PRU | 12.6x | 0.7x | 9.0x | 32.9% | 5.5% | 22.8% |
| PFG | 16.1x | 1.6x | 12.7x | 48.7% | 10.0% | 14.9% |
| UNM | 18.8x | 1.0x | 13.1x | 33.9% | 5.9% | 3.9% |
| GL | 21.8x | 2.2x | 25.9x | 17.0% | 19.6% | 8.9% |
| PRI | 13.5x | 3.0x | 10.7x | 62.0% | 23.2% | 8.5% |
| Peer median | 16.1x | 1.6x | 12.7x | 33.9% | 10.0% | 8.9% |
Frequently asked questions about Oscar Health Inc (OSCR)
Is OSCR stock a good investment?
The TradeMates model rates Oscar Health Inc as HOLD with an investment score of 62/100. OSCR's fundamental turnaround is real, but the risk/reward is balanced here. The model favors holding rather than new entry due to high beta and insider selling. This is algorithmic model output, not personal investment advice.
Is OSCR stock a buy?
The TradeMates model verdict for OSCR is HOLD with an investment score of 62/100. Treat this as a model signal to review, not a personal buy recommendation.